|
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBD |
 |
|
Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease |
|
|
Assessment of cystic fibrosis related liver disease in a pediatric cohort |
|
|
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic... |
|
|
FISPGHAN statement on the global public health impact of metabolic dysfunction-associated steatotic liver disease |
|
|
Primary sclerosing cholangitis in children with inflammatory bowel disease: An ESPGHAN position paper from the Hepatology... |
|
|
Current practice in the management of paediatric autoimmune liver disease in Europe |
|
|
Frailty in children with chronic liver disease: Prevalence and impact on outcomes |
|
|
Topiramate treatment of pediatric metabolic dysfunction-associated steatotic liver disease: A descriptive cohort study |
|
|
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic... |
|
|
Sleep quality in children with hepatic glycogen storage diseases, a prospective observational pilot study |
|
|
Iron and Copper Liver Concentrations in Wilson Disease |
|
